U.S. Regulators Give Full Approval to Pfizer COVID-19 Vaccine
The FDA's action also may spur more vaccine mandates by companies, universities and local governments.
The U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutant yet.
The vaccine made by Pfizer and its partner BioNTech now carries the strongest endorsement from the Food and Drug Administration, which has never before had so much evidence to judge a shot’s safety. More than 200 million Pfizer doses already have been administered in the U.S. — and hundreds of millions more worldwide — since emergency use began in December.
“The public can be very confident that this vaccine meets the high standards for safety, effectiveness and manufacturing quality the FDA requires of an approved product,” said acting FDA Commissioner Janet Woodcock. "Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.”
The U.S. becomes the first country to fully approve the shot, according to Pfizer, and CEO Albert Bourla said in a statement he hoped the decision “will help increase confidence in our vaccine, as vaccination remains the best tool we have to help protect lives.”
U.S. vaccinations bottomed out in July. As delta fills hospital beds, shots are on the rise again — with a million a day given Thursday, Friday and Saturday. Just over half of the U.S. population is fully vaccinated with one of the country’s three options, from Pfizer, Moderna or Johnson & Johnson.
The FDA’s action also may spur more vaccine mandates by companies, universities and local governments. This month New York City, New Orleans and San Francisco all imposed proof-of-vaccination requirements at restaurants, bars and other indoor venues. At the federal level, President Joe Biden is requiring government workers to sign forms attesting that they’ve been vaccinated or else submit to regular testing and other requirements.
Anxious Americans increasingly are on board: Close to 6 in 10 favor requiring people to be fully vaccinated to travel on airplanes or attend crowded public events, according to a recent poll by The Associated Press-NORC Center for Public Affairs Research.
“Mandating becomes much easier when you have full approval,” said Dr. Carlos del Rio of Emory University. “I think a lot of businesses have been waiting for it.”
The FDA, like regulators in Europe and much of the world, initially allowed emergency use of Pfizer’s vaccine based on a study that tracked 44,000 people 16 and older for at least two months — the time period when serious side effects typically arise.
Additional reporting by The Associated Press.
China Eases Controls, Gives No Sign When 'Zero COVID' Ends
China is easing some of the world’s most stringent anti-COVID controls and authorities say new variants are weaker.By Andy Wong / AP
China Eases Virus Controls Amid Effort To Head Off Protests
In some areas, markets and bus service reopened, and a newspaper reported Beijing has begun allowing some people with the virus to isolate at home.By AP Photo
Seniors Are Experiencing Record-High RSV Cases
The latest CDC data from November shows this year, the rate of hospitalization for seniors with RSV is already 10 times higher than average.By Steven Senne / AP
Kirstie Alley, Emmy-Winning 'Cheers' Star, Dies At 71
Kirstie Alley died of cancer that was recently diagnosed, according to a social media post by her children.By Invision / AP
More Businesses Are Purchasing Gun Violence Liability Policies
Expert say incidents are being seen in court as less a "meteor falling from sky" and more of something that companies should be prepared for.By Stephen Spillman / AP
Sudan's Generals, Pro-Democracy Group Ink Deal To End Crisis
Sudan's coup leaders and the main pro-democracy group signed a deal Monday to establish a civilian-led transitional government.By Marwan Ali / AP